Chemomab Therapeutics Ltd
F:2QV0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Chemomab Therapeutics Ltd
F:2QV0
|
IL |
|
B
|
BCE Inc
XMUN:BCE1
|
CA |
|
Relo Group Inc
F:665
|
JP |
|
TradeDoubler AB
F:T1D
|
SE |
|
Atomera Inc
NASDAQ:ATOM
|
US |
|
V
|
Vedanta Aluminium Metal Ltd
NSE:VAML
|
IN |
|
X
|
Xiabuxiabu Catering Management (China) Holdings Co Ltd
F:0XI
|
CN |
|
M
|
Mensch und Maschine Software SE
XHAM:MUM
|
DE |
|
B
|
BCE Inc
F:BCE1
|
CA |
|
A
|
AUTO1 Group SE
DUS:AG1
|
DE |
|
Relo Group Inc
TSE:8876
|
JP |
|
Xiabuxiabu Catering Management (China) Holdings Co Ltd
HKEX:520
|
CN |
|
T
|
TradeDoubler AB
XBER:T1D
|
SE |
|
Bosch Ltd
BSE:500530
|
IN |
|
S
|
SanDisk Corp
DUS:BW9
|
US |
|
Option Care Health Inc
NASDAQ:OPCH
|
US |
|
Mensch und Maschine Software SE
LSE:0RS2
|
DE |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
IL |
Bankruptcy Probability
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Chemomab Therapeutics Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IL |
|
Chemomab Therapeutics Ltd
NASDAQ:CMMB
|
13.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
441.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
196.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
126.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
70.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Chemomab Therapeutics Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Chemomab Therapeutics Ltd has no debt.
You can find a full breakdown on its Balance Sheet.
